Tech Company Financing Transactions
Axcella Health Funding Round
Axcella Health closed a $12.3 million Series B investment round on 2/13/2014. Investors included Flagship Pioneering and private investors.
Transaction Overview
Company Name
Announced On
2/13/2014
Transaction Type
Venture Equity
Amount
$12,250,000
Round
Series B
Investors
Flagship Pioneering (Lead Investor) (Noubar Afeyan)
Proceeds Purpose
The proceeds will fund the advancement of the ProNutrein pipeline as well as the development of additional candidates as medical foods and supplements, and in a separate business unit, as therapeutics.
Company Information
Company Status
Publicly-held
Industry
Consumer
Mailing Address
840 Memorial Dr.
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Not Recorded
Overview
Axcella Health (Nasdaq: AXLA) is a pioneer in developing transformative medicines for patients with diseases in which disrupted amino acid biology plays a central role.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Connelly
Chief Financial Officer
Thomas Leggett
Chief Information Officer
David Berry
Chief Medical Officer
Manu Chakravarthy
VP - Bus. Development
Ivana Magovcevic-Liebisch
VP - R & D
Michael Hamill
VP - R & D
Tony Tramontin
Browse more venture capital transactions:
Prev: 2/13/2014: Tintri venture capital transaction
Next: 2/13/2014: Abusix venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to record tech company VC transactions. VC transactions reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs